Cambian sell-off ‘overdone’

Shares in specialist care provider Cambian have begun a slow recovery following their collapse after the company announced that year-end EBITDA would fall below expectations.Investec has lowered the target price to 210p but, along with other analysts, gave the company a ‘buy’ rating. Meanwhile, a number of the company’s directors, including chief executive Saleem Asaria,…